Parenterāli ievadāmo zāļu iegāde onkoloģisko saslimšanu ārstēšanai 2019. gadam
Nacionālais veselības dienests
Published and bidding deadline .
Integrity Indicators
1 out of 3- No disputes from bidders or outsiders
- Sellers have recently made political party donations
- Bidding period is associated with an increased risk factor
Estimated Cost
Actual Cost
Duration
28 daysBidders
0 biddersBids
0 bidsDisputes
0 disputesParenterāli ievadāmo zāļu iegāde onkoloģisko saslimšanu ārstēšanai 2019. gadam.
Process Type | Open procedure |
---|---|
Offers Revealed At |
Contracts
AS "RECIPE PLUS"award-1. Ondansetronum 8 mg/4 ml — 4 ml Signed . | €1.86M | |||||||||||||||
Political donations by board-members prior to contract totalling €15,000.
| ||||||||||||||||
Sabiedrība ar ierobežotu atbildību "MAGNUM MEDICAL"award-10. Ondansetronum 8mg/4ml - 4 ml Signed . | €1.86M | |||||||||||||||
SIA "UNIFARMA"award-11. Palonosetronum 250 mkg/5 ml – 5 ml Signed . | €1.86M | |||||||||||||||
Sabiedrība ar ierobežotu atbildību "MAGNUM MEDICAL"award-12. Fotemustinum 200 mg/ 4 ml - 4 ml Signed . | €1.86M | |||||||||||||||
SIA "Oribalt Rīga"award-13. Fotemustinum 200 mg/ 4 ml - 4 ml Signed . | €1.86M | |||||||||||||||
SIA "Oribalt Rīga"award-14. Gemcitabinum 40 mg/ml – 50 ml, 100 mg/ml – 20 ml, 2000 mg Signed . | €1.86M | |||||||||||||||
AS "RECIPE PLUS"award-15. Gemcitabinum 40 mg/ml – 25 ml, 100 mg/ml – 10 ml, 1000 mg Signed . | €1.86M | |||||||||||||||
Political donations by board-members prior to contract totalling €15,000.
| ||||||||||||||||
AS "RECIPE PLUS"award-16. Gemcitabinum 40 mg/ml – 5 ml, 200 mg Signed . | €1.86M | |||||||||||||||
Political donations by board-members prior to contract totalling €15,000.
| ||||||||||||||||
SIA "Oribalt Rīga"award-17. Fluorouracilum 50 mg/ml – 100 ml Signed . | €1.86M | |||||||||||||||
SIA "Oribalt Rīga"award-18. Fluorouracilum 50 mg/ml – 20 ml Signed . | €1.86M | |||||||||||||||
AS "RECIPE PLUS"award-19. Fluorouracilum 50 mg/ml – 10 ml Signed . | €1.86M | |||||||||||||||
Political donations by board-members prior to contract totalling €15,000.
| ||||||||||||||||
AS "RECIPE PLUS"award-2. Methotrexatum 20 mg/ml – 1,25 ml, 25 mg/ml – 1 ml, 50 mg/ml – 0,5 ml Signed . | €1.86M | |||||||||||||||
Political donations by board-members prior to contract totalling €15,000.
| ||||||||||||||||
SIA "Oribalt Rīga"award-20. Fluorouracilum 50 mg/ml – 5 ml Signed . | €1.86M | |||||||||||||||
Sabiedrība ar ierobežotu atbildību "ELVIM"award-21. Methotrexatum 20 mg/ ml - 1 ml, 25 mg/ ml - 0.8 ml, 50 mg/ ml - 0.4 ml Signed . | €1.86M | |||||||||||||||
AS "RECIPE PLUS"award-22. Fotemustinum 200 mg/ 4 ml - 4 ml Signed . | €1.86M | |||||||||||||||
Political donations by board-members prior to contract totalling €15,000.
| ||||||||||||||||
AS "RECIPE PLUS"award-23. Docetaxelum 10 mg/ml – 16 ml, 20 mg/ml – 8 ml Signed . | €1.86M | |||||||||||||||
Political donations by board-members prior to contract totalling €15,000.
| ||||||||||||||||
Sabiedrība ar ierobežotu atbildību "Tamro"award-24. Docetaxelum 10 mg/ml – 8 ml, 20 mg/ml – 4 ml Signed . | €1.86M | |||||||||||||||
Sabiedrība ar ierobežotu atbildību "MAGNUM MEDICAL"award-25. Docetaxelum 10 mg/ml – 2 ml, 20 mg/ml – 1 ml Signed . | €1.86M | |||||||||||||||
SIA "SAULES APTIEKA"award-26. Fluorouracilum 50 mg/ ml - 5 ml Signed . | €1.86M | |||||||||||||||
Sabiedrība ar ierobežotu atbildību "ELVIM"award-27. Methotrexatum 20 mg/ ml - 1.25 ml, 25 mg/ ml - 1 ml, 50 mg/ ml - 0.5 ml Signed . | €1.86M | |||||||||||||||
SIA "UNIFARMA"award-28. Doxorubicinum 2 mg/ml – 25 ml, 50 mg Signed . | €1.86M | |||||||||||||||
AS "RECIPE PLUS"award-29. Cytarabinum 100 mg/ml — 10 ml, 1 000 mg Signed . | €7,756 | |||||||||||||||
Political donations by board-members prior to contract totalling €15,000.
| ||||||||||||||||
SIA "Oribalt Rīga"award-3. Methotrexatum 20 mg/ml – 1 ml, 25 mg/ml – 0,8 ml, 50 mg/ml – 0,4 ml Signed . | €1.86M | |||||||||||||||
Sabiedrība ar ierobežotu atbildību "MAGNUM MEDICAL"award-30. Cytarabinum 100 mg/ml — 10 ml, 1 000 mg Signed . | €19,808.74 | |||||||||||||||
Sabiedrība ar ierobežotu atbildību "ELVIM"award-31. Cytarabinum 100 mg/ml — 10 ml, 1 000 mg Signed . | €29,970 | |||||||||||||||
Sabiedrība ar ierobežotu atbildību "Tamro"award-32. Fluorouracilum 50 mg/ ml - 10 ml Signed . | €1.86M | |||||||||||||||
Sabiedrība ar ierobežotu atbildību "Tamro"award-33. Fluorouracilum 50 mg/ ml - 20 ml Signed . | €1.86M | |||||||||||||||
AS "RECIPE PLUS"award-34. Fluorouracilum 50 mg/ ml - 20 ml Signed . | €1.86M | |||||||||||||||
Political donations by board-members prior to contract totalling €15,000.
| ||||||||||||||||
SIA "SAULES APTIEKA"award-35. Fluorouracilum 50 mg/ ml - 20 ml Signed . | €1.86M | |||||||||||||||
Sabiedrība ar ierobežotu atbildību "Tamro"award-36. Fluorouracilum 50 mg/ ml - 100 ml Signed . | €1.86M | |||||||||||||||
AS "RECIPE PLUS"award-37. Cisplatinum 0,5 mg/ml – 100 ml, 1 mg/ml – 50 ml Signed . | €1.86M | |||||||||||||||
Political donations by board-members prior to contract totalling €15,000.
| ||||||||||||||||
Sabiedrība ar ierobežotu atbildību "Tamro"award-38. Gemcitabinum 40 mg/ ml - 5 ml, 200 mg Signed . | €1.86M | |||||||||||||||
AS "RECIPE PLUS"award-39. Gemcitabinum 40 mg/ ml - 5 ml, 200 mg Signed . | €1.86M | |||||||||||||||
Political donations by board-members prior to contract totalling €15,000.
| ||||||||||||||||
AS "RECIPE PLUS"award-4. Fotemustinum 200 mg/4 ml – 4 ml Signed . | €1.86M | |||||||||||||||
Political donations by board-members prior to contract totalling €15,000.
| ||||||||||||||||
SIA "UNIFARMA"award-40. Carboplatinum 150 mg, 10 mg/ml – 15 ml Signed . | €1.86M | |||||||||||||||
SIA "SAULES APTIEKA"award-41. Gemcitabinum 40 mg/ ml - 50 ml, 100 mg/ ml - 20 ml, 2000 mg Signed . | €1.86M | |||||||||||||||
AS "RECIPE PLUS"award-42. Gemcitabinum 40 mg/ ml - 50 ml, 100 mg/ ml - 20 ml, 2000 mg Signed . | €1.86M | |||||||||||||||
Political donations by board-members prior to contract totalling €15,000.
| ||||||||||||||||
SIA "UNIFARMA"award-43. Gemcitabinum 40 mg/ ml - 25 ml, 100 mg/ ml - 10 ml, 1000 mg Signed . | €1.86M | |||||||||||||||
Sabiedrība ar ierobežotu atbildību "Tamro"award-44. Gemcitabinum 40 mg/ ml - 25 ml, 100 mg/ ml - 10 ml, 1000 mg Signed . | €1.86M | |||||||||||||||
AS "RECIPE PLUS"award-45. Gemcitabinum 40 mg/ ml - 25 ml, 100 mg/ ml - 10 ml, 1000 mg Signed . | €1.86M | |||||||||||||||
Political donations by board-members prior to contract totalling €15,000.
| ||||||||||||||||
Sabiedrība ar ierobežotu atbildību "MAGNUM MEDICAL"award-46. Gemcitabinum 40 mg/ ml - 5 ml, 200 mg Signed . | €1.86M | |||||||||||||||
AS "RECIPE PLUS"award-47. Calcii folinatum 10 mg/ml – 10 ml Signed . | €1.86M | |||||||||||||||
Political donations by board-members prior to contract totalling €15,000.
| ||||||||||||||||
Sabiedrība ar ierobežotu atbildību "Tamro"award-48. Calcii folinatum 10 mg/ml – 5 ml Signed . | €1.86M | |||||||||||||||
SIA "UNIFARMA"award-49. Gemcitabinum 40 mg/ ml - 50 ml, 100 mg/ ml - 20 ml, 2000 mg Signed . | €1.86M | |||||||||||||||
Sabiedrība ar ierobežotu atbildību "MAGNUM MEDICAL"award-5. Thyrotropinum 0.9 mg Signed . | €1.86M | |||||||||||||||
Sabiedrība ar ierobežotu atbildību "Tamro"award-6. Thyrotropinum 0.9 mg Signed . | €1.86M | |||||||||||||||
SIA "SAULES APTIEKA"award-7. Palonosetronum 250 mkg/ 5 ml - 5 ml Signed . | €1.86M | |||||||||||||||
Sabiedrība ar ierobežotu atbildību "Tamro"award-8. Palonosetronum 250 mkg/ 5 ml - 5 ml Signed . | €1.86M | |||||||||||||||
AS "RECIPE PLUS"award-9. Palonosetronum 250 mkg/ 5 ml - 5 ml Signed . | €1.86M | |||||||||||||||
Political donations by board-members prior to contract totalling €15,000.
|